Latest News:
  • Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
  • CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
  • BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
  • Nextech AR Signs Poly Deal
  • Ready for New Cannabis and Psychedelics Boom Ahead: CEOs of Aphria, Icanic Brands, Red Light Holland, and Tilray Discuss New Global Market Opportunities

Stock Day Media

Ticker Tape by TradingView

  • News
  • Radio Show
    • Be on our Show!
    • Video Interviews
  • Technology
  • Cannabis
  • Energy
  • BioTech
  • Mining
  • Contact Us
    • About Us
    • Suggestion Box
Subscribe to the latest in penny stock micro-cap news and stock podcasts, straight to your inbox.
Subscribe Now

strontium89

BioTech 

Strontium89 Now Reimbursed in Hospital and Outpatient Settings for Metastatic Bone Pain Treatment

January 7, 2021January 7, 2021 Stock Day Media 107 Views metasticbonepain, outpatient, qbio, reimbursed, strontium89

Strontium89 Now Reimbursed in All Treatment Settings PR Newswire NEW YORK, Jan. 7, 2021 NEW YORK, Jan. 7, 2021 /PRNewswire/ — Q BioMed

Read more
BioTech 

Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and Europe

September 15, 2020September 15, 2020 Stock Day Media 304 Views Europe, qbio, qbiomed, strontium89

Several International Market Authorisations Expected in Q4 Expanding Access to South and Central America and Asia PR Newswire NEW YORK,

Read more
BioTech 

Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain Palliation in EU and Rest of World

August 11, 2020August 11, 2020 Stock Day Media 341 Views EU, qbio, qbiomed, september, strontium89

PR Newswire NEW YORK, Aug. 11, 2020 NEW YORK, Aug. 11, 2020 /PRNewswire/ — Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced

Read more
BioTech 

Q BioMed Adds to Leadership Team With Global Head of Regulatory Affairs

March 31, 2020March 31, 2020 Stock Day Media 314 Views qbio, qbiomed, strontium89

Initial focus on global rollout of Strontium89 PR Newswire NEW YORK, March 31, 2020 NEW YORK, March 31, 2020 /PRNewswire/ — Q BioMed

Read more
Top 5 Penny Stock Picks

Latest News

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
BioTech 

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

January 15, 2021 Stock Day Media Comments Off on Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

NEW YORK, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
BioTech 

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients

January 15, 2021 Stock Day Media Comments Off on CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
BioTech 

BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders

January 15, 2021 Stock Day Media Comments Off on BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
Nextech AR Signs Poly Deal
Technology 

Nextech AR Signs Poly Deal

January 15, 2021 Stock Day Media Comments Off on Nextech AR Signs Poly Deal
Copyright © 2021 Stock Day Media. All rights reserved.